Asthma presents a large burden to the U.S. healthcare system, and an unmet need for more advanced treatment of asthma persists.
During this live webinar, Pfizer and Veeva will discuss how they modeled asthma exacerbation risk factors using patient claims data, HCP/HCO data, U.S. Census data, and other sources.
Their findings show how patient data can be integral to identifying the right patient subgroups for drug development to inform better disease management strategies for patients.
They’ll also share strategies for integrating multiple data sources and selecting the right model for the data.
Andres Quintero, M.D., M.P.H., M.B.A., Global Medical Affairs Director, Glucocorticoid Portfolio Lead, Pfizer
Patryk Skowron, Ph.D., Data Scientist, Veeva